Trademarkia Logo

United Kingdom

£
Trademark Search
Secretomix

View On IPO.GOV.UK

Registered

on 25 Mar 2020

Last Applicant/ Owned by

Micregen Ltd

Regency House, 45-53 Chorley New Road

Bolton, , BL1 4QR

Serial Number

UK00003477179 filed on 25th Mar 2020

Registration Number

UK00003477179 registered on
1st Jan 2021

Secretomix

stem cells for research or scientific purposes; biological preparations and activators; diagnostic preparations for scientific use; clinical chemistry Read More

Classification Information

Class [1]
Chemical Products

Stem cells for research or scientific purposes; biological preparations and activators; diagnostic preparations for scientific use; clinical chemistry and microbiology namely biological serum in an excipient derived from a stem cell; cryogenic preparations;Active chemical ingredients for use in the manufacture of pharmaceuticals.

Class [3]
Cosmetics and Cleaning Products

Anti-ageing creams.

Class [5]
Pharmaceutical Products

Pharmaceutical agents affecting digestive organs;Pharmaceutical agents affecting metabolism;Pharmaceutical agents affecting peripheral nervous system;Pharmaceutical agents affecting sensory organs;Pharmaceutical agents for epidermis;Pharmaceutical compositions;Pharmaceutical drugs;Pharmaceutical preparations;Pharmaceutical preparations acting on the central nervous system;Pharmaceutical preparations and substances;Pharmaceutical preparations and substances for the prevention of cancer;Pharmaceutical preparations and substances for the treatment of cancer;Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;Pharmaceutical preparations and substances for use in oncology;Pharmaceutical preparations and substances with anti-inflammatory properties;Pharmaceutical preparations for activating cellular function;Pharmaceutical preparations for animals;Pharmaceutical preparations for human use;Pharmaceutical preparations for immunity adjustment;Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension;Pharmaceutical preparations for medical purposes;Pharmaceutical preparations for ocular or intraocular surgery;Pharmaceutical preparations for ophthalmological use;Pharmaceutical preparations for peripheral nervous system;Pharmaceutical preparations for regulating the immune system;Pharmaceutical preparations for skin wounds;Pharmaceutical preparations for suppressing tumors;Pharmaceutical preparations for the prevention of autoimmune diseases;Pharmaceutical preparations for the prevention of autoimmune disorders;Pharmaceutical preparations for the prevention of diabetes;Pharmaceutical preparations for the prevention of diseases of the cardio-vascular system;Pharmaceutical preparations for the prevention of diseases of the endocrine system;Pharmaceutical preparations for the prevention of diseases of the immune system;Pharmaceutical preparations for the prevention of diseases of the metabolic system;Pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system;Pharmaceutical preparations for the prevention of diseases of the nervous system;Pharmaceutical preparations for the prevention of diseases of the respiratory system;Pharmaceutical preparations for the prevention of disorders of the cardio-vascular system;Pharmaceutical preparations for the prevention of disorders of the endocrine system;Pharmaceutical preparations for the prevention of disorders of the immune system;Pharmaceutical preparations for the prevention of disorders of the metabolic system;Pharmaceutical preparations for the prevention of disorders of the musculo-skeletal system;Pharmaceutical preparations for the prevention of disorders of the nervous system;Pharmaceutical preparations for the prevention of disorders of the respiratory system;Pharmaceutical preparations for the prevention of inflammatory diseases;Pharmaceutical preparations for the prevention of inflammatory disorders;Pharmaceutical preparations for the prevention of ocular diseases;Pharmaceutical preparations for the prevention of ocular disorders;Pharmaceutical preparations for the prevention of osteoporosis;Pharmaceutical preparations for the prevention of tumours;Pharmaceutical preparations for the treatment of Musculo-skeletal disorders;Pharmaceutical preparations for the treatment of Parkinson's disease;Pharmaceutical preparations for the treatment of autoimmune diseases;Pharmaceutical preparations for the treatment of autoimmune disorders;Pharmaceutical preparations for the treatment of bone diseases;Pharmaceutical preparations for the treatment of bone fractures;Pharmaceutical preparations for the treatment of cancer;Pharmaceutical preparations for the treatment of cardiovascular disease;Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases;Pharmaceutical preparations for the treatment of digestive diseases;Pharmaceutical preparations for the treatment of diseases of the endocrine system;Pharmaceutical preparations for the treatment of diseases of the metabolic system;Pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system;Pharmaceutical preparations for the treatment of disorders of the endocrine system;Pharmaceutical preparations for the treatment of disorders of the metabolic system;Pharmaceutical preparations for the treatment of eye diseases and conditions;Pharmaceutical preparations for the treatment of hormonal disorders;Pharmaceutical preparations for the treatment of immune system related diseases and disorders;Pharmaceutical preparations for the treatment of inflammatory diseases;Pharmaceutical preparations for the treatment of inflammatory disorders;Pharmaceutical preparations for the treatment of multiple sclerosis;Pharmaceutical preparations for the treatment of musculo-skeletal disorders;Pharmaceutical preparations for the treatment of osteoporosis;Pharmaceutical preparations for the treatment of tumours;Pharmaceutical preparations for the treatment of viral diseases;Pharmaceutical preparations for treating arthritis;Pharmaceutical preparations for treating chemical imbalances;Pharmaceutical preparations for treating diabetes;Pharmaceutical preparations for treating digestive system disorders;Pharmaceutical preparations for treating gastrointestinal disorders;Pharmaceutical preparations for treating malignant tumors;Pharmaceutical preparations for treating metabolic disorders;Pharmaceutical preparations for treating peripheral nervous system disorders;Pharmaceutical preparations for treating respiratory diseases;Pharmaceutical preparations for treating rheumatological diseases;Pharmaceutical preparations for treating sensory organ disorders;Pharmaceutical preparations for treating skeletal diseases;Pharmaceutical preparations for treating sports injuries;Pharmaceutical preparations for use in hematology;Pharmaceutical preparations for use in oncology;Pharmaceutical preparations for use in ophthalmology;Pharmaceutical preparations for veterinary use;Pharmaceutical preparations for wounds;Pharmaceutical products for ophthalmological use;Pharmaceutical products for the treatment of cancer;Pharmaceutical products for the treatment of viral diseases;Pharmaceutical products for treating respiratory diseases.

Class [39]
Transportation & Storage Services

Cryogenic storage;Cryogenic storage of biological tissue intended for subsequent implantation.

Class [40]
Treatment & Processing of Materials Services

Cryogenic preservation.

Class [42]
Computer & Software Services & Scientific Services

Pharmaceutical drug development services;Pharmaceutical products development;Pharmaceutical research and development;Pharmaceutical research and development services;Pharmaceutical research services.

Class [44]
Medical, Beauty & Agricultural Services

Stem cell storage.

Mark Details

Serial Number

UK00003477179

Mark Type

Word

Kind of mark

Individual